Cargando…
Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line
Eribulin is a new drug to treat soft tissue sarcoma (STS) that exerts antitumor activity by binding to microtubules. The prognosis of STS is poor, and eribulin is expected to improve the treatment outcome. We observed several cases that exhibited resistance to eribulin and developed an eribulin-resi...
Autores principales: | Yahiro, Kenichiro, Matsumoto, Yoshihiro, Fukushi, Jun-ichi, Kawaguchi, Ken-ichi, Endo, Makoto, Setsu, Nokitaka, IIda, Keiichiro, Fukushima, Suguru, Nakagawa, Makoto, Kimura, Atsushi, Oda, Yoshinao, Nakashima, Yasuharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033248/ https://www.ncbi.nlm.nih.gov/pubmed/30034996 http://dx.doi.org/10.1155/2018/8987568 |
Ejemplares similares
-
Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor
por: Fukushima, Suguru, et al.
Publicado: (2018) -
Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor
por: Fukushima, Suguru, et al.
Publicado: (2017) -
Clinical Outcome and Prognostic Factors of Malignant Spinal Dumbbell Tumors
por: Matsumoto, Yoshihiro, et al.
Publicado: (2018) -
Evaluation of Risk Factors for Vertebral Compression Fracture after Carbon-Ion Radiotherapy for Primary Spinal and Paraspinal Sarcoma
por: Matsumoto, Yoshihiro, et al.
Publicado: (2017) -
Nuclear β-catenin translocation plays a key role in osteoblast differentiation of giant cell tumor of bone
por: Kimura, Atsushi, et al.
Publicado: (2022)